Miromatrix Medical Inc
NASDAQ:MIRO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Miromatrix Medical Inc
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Miromatrix Medical Inc
NASDAQ:MIRO
|
93m USD | -2.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
218.4B USD | 22.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
188.7B USD | 17 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.8B CHF | 18.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
38.8B USD | 15.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
37.9B USD | 25 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
52T KRW | 30.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
31.1B USD | 27.3 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.9B USD | 17.1 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
24.3B USD | 29.6 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
130.8B CNY | 11.5 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
You don't have any saved screeners yet
